Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Group program for Spanish speakers living with long COVID symptoms

Tests a Spanish group program that builds coping skills in adults with long COVID.

Plain-language title generated from the registry record
Registry title: Harnessing Optimism and Perseverance in the Face of Long COVID-Español

Key facts

Where
New York, United StatesSee the site

Where in United States

  • Brain Injury Research CenterNew York, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Icahn School of Medicine at Mount Sinai
Trial code
NCT07216040
Record updated
23 April 2026
Original description
The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.Read full original descriptionShow less

Harnessing Optimism and Perseverance in the Face of Long COVID~Español (HOPE-LC~Español)

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.

Inclusion: Age 18 years or older; Speaks and understands Spanish at a level that allows active participation in group-based study procedures; Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms; Ability to participate in group sessions either in-person or via telehealth (Zoom); Willingness and capacity to provide informed consent.

Exclusion: Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms; Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention); Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions; Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations.

ClinicalTrials.gov NCT07216040